The candidates in the running to be the next Society for Vascular Surgery (SVS) vice president—and a future SVS president—have been unveiled.
They are William Shutze, MD, and Joseph Mills, MD, both of whom operate in Texas and who, respectively, represent the worlds of community vascular surgery and academic practice.
Shutze first entered private practice in Dallas in 1991, and in 1997 joined the Dallas- and Plano-based Texas Vascular Associates, where he remains as a partner. Operating from a community setting, he is credited with authorship or co-authorship of nearly 80 peer-reviewed publications. Among the numerous SVS positions he has held, Shutze currently serves as the chair of the Clinical Practice Council.
He listed his favorite accomplishments thus far as developing the SVS Mentor Match program as well as the Society’s Community Practice Section. “I am humbled and honored for this nomination and I am grateful for the opportunities given me to serve my colleagues, friends, peers and patients,” Shutze told the SVS.
Mills is currently chief in the division of vascular surgery and endovascular therapy at Baylor College of Medicine in Houston, counting extensive clinical experience in multiple practice settings, including military, Veterans Administration (VA), county, university and private hospitals.
He has authored more than 300 peer-reviewed journal articles and book chapters, and is co-founder of the Southern Arizona Limb Salvage Alliance (SALSA). A past-president of the Association of Program Directors in Vascular Surgery (APDVS), Mills has served the SVS as treasurer and chair of the Distinguished Fellows Council. Most recently, he has led the Public and Professional Outreach (PPO) Committee, helping spearhead the SVS branding campaign.
Active and Senior members in good standing may cast their ballots until 5 p.m. Central Daylight Time on Monday, May 24. Votes can be cast at vascular.org/vote2021. The candidate with the most votes will be announced at the SVS virtual Annual Business Meeting on June 16.
The meeting will also mark the SVS presidential handover from Ronald L. Dalman, MD, to Ali AbuRahma, MD, as well as the unveiling of the entire SVS officer and Strategic Board lineup.